Results 141 to 150 of about 34,412 (225)

Reduced CC Chemokine Receptor 4 Expression in Tumor Cells after Lenalidomide Treatment for Adult T-Cell Leukemia/Lymphoma: A Case Report

open access: yesCase Reports in Oncology
Introduction: CC chemokine receptor 4 (CCR4), which is involved in leukocyte migration, is expressed in most tumor cells in patients with adult T-cell leukemia/lymphoma (ATLL).
Masatomo Shimizu   +5 more
doaj   +1 more source

A Narrative Review of the State of the Art of CCR4-Based Therapies in Cutaneous T-Cell Lymphomas: Focus on Mogamulizumab and Future Treatments

open access: yesAntibodies
The CCR4 receptor is a pivotal target in cutaneous T-cell lymphoma (CTCL) therapy due to its role in impairing immune responses against malignant T-cells and expression profiles. Monoclonal antibodies like mogamulizumab effectively bind to CCR4, reducing
Corrado Zengarini   +7 more
doaj   +1 more source

Cytokines and chemokines in Mycobacterium tuberculosis infection [PDF]

open access: yes, 2016
Cooper, Andrea   +3 more
core   +2 more sources

CAR T cells targeting CCR4 selectively deplete human Tregs ex vivo and in vivo. [PDF]

open access: yesBlood Adv
Tilsed CM   +14 more
europepmc   +1 more source

The CCL17-CCR4 Axis Is Critical for Mutant STAT6-Mediated Microenvironmental Remodeling and Therapeutic Resistance in Relapsed/Refractory Diffuse Large B-Cell Lymphoma. [PDF]

open access: yesCancer Immunol Res
Abraham MJ   +13 more
europepmc   +1 more source

Integrated genetic analyses identified T-cell neoplasms other than adult T-cell leukemia/lymphoma in HTLV-1 carriers. [PDF]

open access: yesBlood Adv
Naito Y   +19 more
europepmc   +1 more source

Peripheral Blood Skin-Homing T Cells Define Immunological Endotypes in Atopic Dermatitis: A Case-Control Study in a Mexican Population. [PDF]

open access: yesHealth Sci Rep
Luis Carlos ZP   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy